HARVARD BIOSCIENCE, INC.: 10-Q filed 2021-11-05
What HARVARD BIOSCIENCE, INC. reported in its quarterly report filed 2021-11-05 (fiscal Q3 2021): 49 published measures, 132 facts as tagged in accession 0001171843-21-007633.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-11-05
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001171843-21-007633 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HARVARD BIOSCIENCE, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 153,872,000 | USD | |
| At 2020-12-31 | 156,254,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 76,985,000 | USD | |
| At 2020-12-31 | 79,573,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 76,887,000 | USD | |
| At 2021-06-30 | 78,701,000 | USD | |
| At 2020-12-31 | 76,681,000 | USD | |
| At 2020-09-30 | 77,167,000 | USD | |
| At 2020-06-30 | 76,068,000 | USD | |
| At 2019-12-31 | 81,694,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 5,548,000 | USD | |
| At 2020-12-31 | 8,317,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -170,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -1,249,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -1,098,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -7,195,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 1,145,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 6,841,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 837,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 1,088,000 | USD | 274 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 29,663,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 85,849,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 24,037,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 71,116,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -2,846,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -11,324,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -987,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -1,088,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -133,635,000 | USD | |
| At 2020-12-31 | -132,386,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 40,754 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 40,202 | shares | 273 |
| 2020-07-01 to 2020-09-30 | 38,920 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 38,540 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 40,754 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 40,202 | shares | 273 |
| 2020-07-01 to 2020-09-30 | 38,920 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 38,540 | shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 215,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -22,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -317,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 451,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 3,453,000 | USD | |
| At 2020-12-31 | 3,960,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 3,136,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 2,641,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 548,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 367,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 182,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -2,535,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 55,686,000 | USD | |
| At 2020-12-31 | 51,700,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 23,506,000 | USD | |
| At 2020-12-31 | 21,053,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 5,616,000 | USD | |
| At 2020-12-31 | 5,972,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 57,987,000 | USD | |
| At 2020-12-31 | 58,590,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 28,698,000 | USD | |
| At 2020-12-31 | 32,897,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 18,340,000 | USD | |
| At 2020-12-31 | 17,766,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 15,760,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 47,725,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 13,313,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 42,868,000 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 25,978,000 | USD | |
| At 2020-12-31 | 22,262,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 16,308,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 48,092,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 13,495,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 40,333,000 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 2,660,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 7,848,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 1,949,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 6,336,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 40,809,018 | shares | |
| At 2020-12-31 | 39,407,080 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -15,003,000 | USD | |
| At 2020-12-31 | -13,066,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 7,081,000 | USD | |
| At 2020-12-31 | 7,761,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 8,843,000 | USD | |
| At 2020-12-31 | 9,592,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 45,210,000 | USD | |
| At 2020-12-31 | 48,007,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 28,941,000 | USD | |
| At 2020-12-31 | 33,151,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 724,000 | USD | |
| At 2020-12-31 | 1,092,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 2,474,000 | USD | |
| At 2020-12-31 | 2,854,000 | USD |
Current contract liabilities
Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 3,623,000 | USD | |
| At 2020-12-31 | 3,771,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 1,549,000 | USD | |
| At 2020-12-31 | 1,899,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 45,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -1,271,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -1,415,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -6,744,000 | USD | 274 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -1,305,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -3,186,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 632,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -6,480,000 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 5,458,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 18,190,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 5,399,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 17,828,000 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 1,311,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 1,453,000 | USD | 274 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 1,459,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 4,388,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 1,377,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 4,258,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -130,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -477,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -392,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -472,000 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -503,000 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -1,638,000 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -1,597,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -4,209,000 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 836,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 3,795,000 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 506,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 410,000 | USD | 274 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 1,791,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 2,041,000 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 727,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -6,805,000 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 4,048,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 511,000 | USD | 274 |
Inspect the source
- Entity
- HARVARD BIOSCIENCE, INC. / CIK 0001123494
- Captured
- 2026-09-20T07:40:12.981Z
- SEC response SHA-256
8cc75879b3fed76d9c61a35acdcb8854141b1c291e36d605fbb5def8324a6fc5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001123494.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))